The New Standard in Wealth Management, Wealth Management Alliance

Wealth Management Alliance

The New Standard in Wealth Management

WMA is a Singapore-based multi-family office with a Capital Markets Services license and provide fund management and investment advisory services to a small number of global UHNW clients. We also act as incubator for single-family offices, allowing them to plug into our broader ecosystem and infrastructure, and tap on our investment professionals for advice. WMA is designed around providing truly bespoke advice to each client, rather than taking a one-size-fits-all approach that may not fit each client's investment objectives and risk tolerances. On top of that, we are designed so that we avoid any semblance of conflicts of interests by being compensated only by the client (which may include profit sharing), as opposed to the model that many of our peers adopt, which include compensation from a variety of third parties such as funds managers, distributors or banks. That, to us, is the easiest way to be firmly on the side of the client in every decision we make.

Thematic (Sector/Industry)

<ul><li>The global medical technology (MedTech) market is estimated to hit the USD1 trillion mark by mid to late 2030s, driven by aging populations, a growing incidence of chronic diseases and improving technology. Asia Pacific accounts for an estimated 20-25% of the global market, with growth underpinned by rising middle-class demand.</li><li>Singapore is a leading MedTech manufacturing and innovation hub in the region, as well as a key component of the country’s biomedical sector.</li><li>Singapore’s overall MedTech industry is highly vibrant, given the presence of the world’s top multinationals operating here, to account for some 80-90% of the industry’s total output.</li></ul>

The global medical technology (MedTech) market is estimated to hit the USD1 trillion mark by mid to late 2030s, driven by aging populations, a growing incidence of chronic diseases and improving technology. Asia Pacific accounts for an estimated 20-25% of the global market, with growth underpinned by rising middle-class demand.Singapore is a leading MedTech manufacturing and innovation hub in the region, as well as a key component of the country’s biomedical sector.Singapore’s overall MedTech industry is highly vibrant, given the presence of the world’s top multinationals operating here, to account for some 80-90% of the industry’s total output.

Singapore Medtech Industry: High Growth but a Critical Mass Will Hinge on More Company Listings

Singapore

Clearbridge Health is an integrated healthcare group focused on precision medicine, offering laboratory testing services, operating medical clinics/centers, and investing in precision medical technology companies. The company provides a range of services including clinical diagnostics, imaging, general health screenings, and specialized medical services across Singapore, the Philippines, Hong Kong, and Malaysia. It was incorporated in 2010 and is headquartered in Singapore.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Clearbridge Health (CBH SP)

Singapore Medtech Industry: High Growth but a Critical Mass Will Hinge on More Company Listings

The global medical technology (MedTech) market is estimated to hit the USD1 trillion mark by mid to late 2030s, driven by aging populations, a...

Wealth Management Alliance

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)